Skip to content

Inhibrx Biosciences, Inc. INBX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Rogers Corporation logo
Rogers CorporationROG
$18.5M-20.9%
Nuvation Bio logo
Nuvation BioNUVB
$3.6M-32.5%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$370K+208%
Immunome logo
ImmunomeIMNM
$2.83M-32.1%
Replimune Group logo
Replimune GroupREPL
$3.5M-15.1%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$22.61M-7.4%

Other financials

Income statement

See full
Revenue--100%
Operating income-$30.9M+27.9%
Net income-$33.4M+22.8%
EPS (diluted)-$2.15+23.2%

Balance sheet

See full
Cash & equivalents$161.7M-25.3%
Total debt$180.9M+69.8%
Total equity-$21.0M-122%
Total assets$184.0M-24.2%

Cash flow

See full
Operating cash flow-$38.0M-5.9%
CapEx--100%
Free cash flow-$38.0M-5.9%

Valuation

See full
Market cap$1.4B+546%
Enterprise value$1.42B+1,233%
P/S1,073.7×-280×

Profitability

See full
Operating margin-10,386.5%-5,025pp
Net margin-10,773.5%-878,492pp
FCF margin-9,986.5%-4,727pp

Returns & leverage

See full
Return on equity-197.8%-2,158pp
Debt / equity13.4×+13.3×
Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s operating lease ROU assets?
Inhibrx Biosciences, Inc. (INBX) reported operating lease ROU assets of $5.05M in Q1 2026.
How has Inhibrx Biosciences, Inc.'s operating lease ROU assets changed year-over-year?
Inhibrx Biosciences, Inc.'s operating lease ROU assets decreased by 26.8% year-over-year, from $6.9M to $5.05M.
What is the long-term trend for Inhibrx Biosciences, Inc.'s operating lease ROU assets?
Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s operating lease ROU assets has grown at a 36.9% compound annual growth rate (CAGR), from $2.95M to $5.54M.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.